• Something wrong with this record ?

Efficacy of gamma interferon and specific antibody for treatment of microsporidiosis caused by Encephalitozoon cuniculi in SCID mice

J Salat, J Jelinek, J Chmelar, J Kopecky

. 2008 ; 52 (6) : 2169-2174.

Language English Country United States

E-resources

NLK Free Medical Journals from 1972 to 6 months ago
Freely Accessible Science Journals from 1995 to 6 months ago
PubMed Central from 1972 to 1 year ago
Europe PubMed Central from 1972 to 6 months ago
Open Access Digital Library from 1972-01-01
Open Access Digital Library from 1972-01-01

Microsporidia are eukaryotic, obligate, intracellular protists that are emerging pathogens in immunocompromised hosts, including AIDS patients and organ transplant recipients. The efficacy of gamma interferon (IFN-gamma) for the treatment of microsporidiosis caused by Encephalitozoon cuniculi was studied by means of adoptive transfer and IFN-gamma administration in SCID mice. While the adoptive transfer of CD4(+) T cells from immunocompetent mice prolonged survival of SCID mice infected perorally with E. cuniculi, survival was not improved by adoptive transfer of CD4(+) T lymphocytes from IFN-gamma-deficient mice. The protective effect of IFN-gamma was confirmed in cytokine therapy experiments in which SCID mice receiving IFN-gamma survived significantly longer than mice receiving mock injections. The administration of serum containing specific antibodies against E. cuniculi was found to prolong the survival of concurrently IFN-gamma-treated SCID mice. The data presented in this study suggest that IFN-gamma is potentially useful as a cytokine therapy for microsporidiosis, especially in CD4(+) T-cell-deficient patients.

000      
03199naa 2200505 a 4500
001      
bmc11003653
003      
CZ-PrNML
005      
20201203122204.0
008      
110302s2008 xxu e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Salát, Jiří $7 xx0105109
245    10
$a Efficacy of gamma interferon and specific antibody for treatment of microsporidiosis caused by Encephalitozoon cuniculi in SCID mice / $c J Salat, J Jelinek, J Chmelar, J Kopecky
314    __
$a Institute of Parasitology and Faculty of Biological Sciences, Biology Centre Academy of Sciences of Czech Republic, Branisovska 31, 370 05 Ceske Budejovice, Czech Republic. george@paru.cas.cz
520    9_
$a Microsporidia are eukaryotic, obligate, intracellular protists that are emerging pathogens in immunocompromised hosts, including AIDS patients and organ transplant recipients. The efficacy of gamma interferon (IFN-gamma) for the treatment of microsporidiosis caused by Encephalitozoon cuniculi was studied by means of adoptive transfer and IFN-gamma administration in SCID mice. While the adoptive transfer of CD4(+) T cells from immunocompetent mice prolonged survival of SCID mice infected perorally with E. cuniculi, survival was not improved by adoptive transfer of CD4(+) T lymphocytes from IFN-gamma-deficient mice. The protective effect of IFN-gamma was confirmed in cytokine therapy experiments in which SCID mice receiving IFN-gamma survived significantly longer than mice receiving mock injections. The administration of serum containing specific antibodies against E. cuniculi was found to prolong the survival of concurrently IFN-gamma-treated SCID mice. The data presented in this study suggest that IFN-gamma is potentially useful as a cytokine therapy for microsporidiosis, especially in CD4(+) T-cell-deficient patients.
650    _2
$a převzatá imunita $7 D019264
650    _2
$a zvířata $7 D000818
650    _2
$a monoklonální protilátky $x imunologie $x terapeutické užití $7 D000911
650    _2
$a specificita protilátek $7 D000918
650    _2
$a CD4-pozitivní T-lymfocyty $x imunologie $7 D015496
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a Encephalitozoon cuniculi $x imunologie $7 D009670
650    _2
$a encephalitozoonóza $7 D016890
650    _2
$a lidé $7 D006801
650    _2
$a imunoterapie $7 D007167
650    _2
$a interferon gama $x aplikace a dávkování $x genetika $x terapeutické užití $7 D007371
650    _2
$a myši $7 D051379
650    _2
$a myši inbrední BALB C $7 D008807
650    _2
$a myši knockoutované $7 D018345
650    _2
$a myši SCID $7 D016513
650    _2
$a výsledek terapie $7 D016896
650    _2
$a financování organizované $7 D005381
700    1_
$a Jelínek, Jiří. $7 xx0300625
700    1_
$a Chmelař, Jindřich. $7 jcu2011636319
700    1_
$a Kopecký, Jan, $d 1950- $7 jx20051102023
773    0_
$t Antimicrobial Agents & Chemotherapy $w MED00009215 $g Roč. 52, č. 6 (2008), s. 2169-2174
910    __
$a ABA008 $b x $y 7 $z 0
990    __
$a 20110413120915 $b ABA008
991    __
$a 20201203122202 $b ABA008
999    __
$a ok $b bmc $g 831068 $s 695674
BAS    __
$a 3
BMC    __
$a 2008 $b 52 $c 6 $d 2169-2174 $m Antimicrobial agents and chemotherapy $n Antimicrob Agents Chemother $x MED00009215
LZP    __
$a 2011-3B/vtme

Find record